Cargando…

Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste

Hemp based cannabinoids have gained popularity in veterinary medicine due to the potential to treat pain, seizure disorders and dermatological maladies in dogs. Cat owners are also using hemp-based products for arthritis, anxiety and neoplastic disorders with no studies assessing hemp cannabinoids,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tongxin, Zakharov, Alex, Gomez, Beatriz, Lyubimov, Alex, Trottier, Nathalie L., Schwark, Wayne S., Wakshlag, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355628/
https://www.ncbi.nlm.nih.gov/pubmed/35937287
http://dx.doi.org/10.3389/fvets.2022.895368
_version_ 1784763337248079872
author Wang, Tongxin
Zakharov, Alex
Gomez, Beatriz
Lyubimov, Alex
Trottier, Nathalie L.
Schwark, Wayne S.
Wakshlag, Joseph J.
author_facet Wang, Tongxin
Zakharov, Alex
Gomez, Beatriz
Lyubimov, Alex
Trottier, Nathalie L.
Schwark, Wayne S.
Wakshlag, Joseph J.
author_sort Wang, Tongxin
collection PubMed
description Hemp based cannabinoids have gained popularity in veterinary medicine due to the potential to treat pain, seizure disorders and dermatological maladies in dogs. Cat owners are also using hemp-based products for arthritis, anxiety and neoplastic disorders with no studies assessing hemp cannabinoids, namely cannabidiol efficacy, for such disorders. Initial twenty-four pharmacokinetic and chronic dosing serum concentration in cats are sparse. The aim of our study was to assess 8 cats physiological and 24 h and 1-week steady state pharmacokinetic response to a cannabidiol (CBD) and cannabidiolic acid (CBDA) rich hemp in a palatable oral paste. Using a standard dose of paste (6.4 mg/CBD + CBDA 5.3 mg/gram) across 8 cats weighing between 4.2 and 5.4 kg showed an average maximal concentration of CBD at 282.0 ± 149.4 ng/mL with a half-life of ~2.1 ± 1.1 h, and CBDA concentrations of 1,011.3 ± 495.4 ng/mL with a half-life of ~2.7 ± 1.4 h, showing superior absorption of CBDA. After twice daily dosing for 1 week the serum concentrations 6 h after a morning dosing showed that the acidic forms of the cannabinoids were approximately double the concentration of the non-acidic forms like CBD and Δ9- tetrahydrocannabinol (THC). The results of this study compared to two other recent studies suggest that the absorption in this specific paste product may be superior to oil bases used previously, and show that the acidic forms of cannabinoids appear to be absorbed better than the non-acidic forms. More importantly, physical and behavioral examinations every morning after dosing showed no adverse events related to neurological function or behavioral alterations. In addition, bloodwork after 1 week of treatment showed no clinically significant serum biochemical alterations as a reflection of hepatic and renal function all remaining within the reference ranges set by the diagnostic laboratory suggesting that short-term treatment was safe.
format Online
Article
Text
id pubmed-9355628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93556282022-08-06 Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste Wang, Tongxin Zakharov, Alex Gomez, Beatriz Lyubimov, Alex Trottier, Nathalie L. Schwark, Wayne S. Wakshlag, Joseph J. Front Vet Sci Veterinary Science Hemp based cannabinoids have gained popularity in veterinary medicine due to the potential to treat pain, seizure disorders and dermatological maladies in dogs. Cat owners are also using hemp-based products for arthritis, anxiety and neoplastic disorders with no studies assessing hemp cannabinoids, namely cannabidiol efficacy, for such disorders. Initial twenty-four pharmacokinetic and chronic dosing serum concentration in cats are sparse. The aim of our study was to assess 8 cats physiological and 24 h and 1-week steady state pharmacokinetic response to a cannabidiol (CBD) and cannabidiolic acid (CBDA) rich hemp in a palatable oral paste. Using a standard dose of paste (6.4 mg/CBD + CBDA 5.3 mg/gram) across 8 cats weighing between 4.2 and 5.4 kg showed an average maximal concentration of CBD at 282.0 ± 149.4 ng/mL with a half-life of ~2.1 ± 1.1 h, and CBDA concentrations of 1,011.3 ± 495.4 ng/mL with a half-life of ~2.7 ± 1.4 h, showing superior absorption of CBDA. After twice daily dosing for 1 week the serum concentrations 6 h after a morning dosing showed that the acidic forms of the cannabinoids were approximately double the concentration of the non-acidic forms like CBD and Δ9- tetrahydrocannabinol (THC). The results of this study compared to two other recent studies suggest that the absorption in this specific paste product may be superior to oil bases used previously, and show that the acidic forms of cannabinoids appear to be absorbed better than the non-acidic forms. More importantly, physical and behavioral examinations every morning after dosing showed no adverse events related to neurological function or behavioral alterations. In addition, bloodwork after 1 week of treatment showed no clinically significant serum biochemical alterations as a reflection of hepatic and renal function all remaining within the reference ranges set by the diagnostic laboratory suggesting that short-term treatment was safe. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9355628/ /pubmed/35937287 http://dx.doi.org/10.3389/fvets.2022.895368 Text en Copyright © 2022 Wang, Zakharov, Gomez, Lyubimov, Trottier, Schwark and Wakshlag. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Wang, Tongxin
Zakharov, Alex
Gomez, Beatriz
Lyubimov, Alex
Trottier, Nathalie L.
Schwark, Wayne S.
Wakshlag, Joseph J.
Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
title Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
title_full Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
title_fullStr Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
title_full_unstemmed Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
title_short Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste
title_sort serum cannabinoid 24 h and 1 week steady state pharmacokinetic assessment in cats using a cbd/cbda rich hemp paste
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355628/
https://www.ncbi.nlm.nih.gov/pubmed/35937287
http://dx.doi.org/10.3389/fvets.2022.895368
work_keys_str_mv AT wangtongxin serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste
AT zakharovalex serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste
AT gomezbeatriz serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste
AT lyubimovalex serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste
AT trottiernathaliel serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste
AT schwarkwaynes serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste
AT wakshlagjosephj serumcannabinoid24hand1weeksteadystatepharmacokineticassessmentincatsusingacbdcbdarichhemppaste